- Report
- May 2026
- 301 Pages
Global
From €2234EUR$2,500USD£1,910GBP
- Report
- August 2026
- 186 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1787EUR$2,000USD£1,528GBP
- Report
- June 2024
- 200 Pages
Global
From €7105EUR$7,950USD£6,073GBP
- Report
- May 2024
- 137 Pages
Global
From €2680EUR$2,999USD£2,291GBP
€3574EUR$3,999USD£3,055GBP
The Skin Disease Drugs market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin diseases and conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Common treatments include topical creams, ointments, and oral medications. Many of these drugs are available over-the-counter, while others require a prescription from a doctor.
The Skin Disease Drugs market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Novartis, Johnson & Johnson, and Merck. Other companies include Allergan, Sanofi, Bayer, and Mylan. Show Less Read more